ATYR Reiterate Overweight and $7 PT as EFZO-FIT Posthoc Analysis Further Supports Ph3 Restrictive Patient Selection @ Piper

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.